In bladder cancer, the major source of increased serum HGF levels is likely the tumor itself (Gohji et al. 2000); several studies have demonstrated the involvement of the HGF/MET pathway in the development of aggressive tumors. The gene discussed is MET; the disease is urinary bladder carcinoma.